In reply - Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

被引：2
|
作者：
Sanchis-Gomar, Fabian [1 ,2 ,3 ]
Lavie, Carl J. [4 ]
Perez-Quilis, Carme [1 ,2 ]
Henry, Brandon M. [5 ]
Lippi, Giuseppe [6 ]
机构：
[1] Univ Valencia, Valencia, Spain
[2] INCLIVA Biomed Res Inst, Valencia, Spain
[3] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[4] Univ Queensland, Sch Med, Ochsner Clin Sch, John Ochsner Heart & Vasc Inst, New Orleans, LA USA
[5] Cincinnati Childrens Hosp Med Ctr, Heart Inst, Cincinnati, OH 45229 USA
[6] Univ Verona, Verona, Italy
来源：
MAYO CLINIC PROCEEDINGS | 2020年 / 95卷 / 07期
关键词：
ALDOSTERONE SYSTEM; COVID-19;
D O I：
10.1016/j.mayocp.2020.05.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1553 / 1556
页数：4
相关论文
共 50 条
  • [1] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis
    Lonn E.
    [J]. Current Atherosclerosis Reports, 2002, 4 (5) : 363 - 372
  • [2] Are angiotensin-converting enzyme inhibitors and angiotensin 2 receptor blockers teratogenic?
    Morton, A. P.
    [J]. DIABETIC MEDICINE, 2013, 30 (10) : 1263 - 1264
  • [3] Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
    Ferrario, CM
    Jessup, J
    Chappell, MC
    Averill, DB
    Brosnihan, KB
    Tallant, EA
    Diz, DI
    Gallagher, PE
    [J]. CIRCULATION, 2005, 111 (20) : 2605 - 2610
  • [4] Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 201p
    Sanchis-Gomar, Fabian
    Lavie, Carl J.
    Perez-Quilis, Carme
    Henry, Brandon M.
    Lippi, Giuseppe
    [J]. MAYO CLINIC PROCEEDINGS, 2020, 95 (06) : 1222 - 1230
  • [5] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction
    Kostis, John B.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 24 (04) : 397 - 397
  • [6] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for the Prevention of Migraines
    Gales, Barry J.
    Bailey, Emilee K.
    Reed, Ashley N.
    Gales, Mark A.
    [J]. ANNALS OF PHARMACOTHERAPY, 2010, 44 (02) : 360 - 366
  • [7] Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers
    Tazkarji, Bachir
    Ganeshamoorthy, Ambika
    Auten, Beth
    [J]. AMERICAN FAMILY PHYSICIAN, 2015, 91 (03) : 193 - 194
  • [8] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy
    Dillon, JJ
    [J]. SEMINARS IN NEPHROLOGY, 2004, 24 (03) : 218 - 224
  • [9] Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus
    Verdecchia, Paolo
    Angeli, Fabio
    Reboldi, Gianpaolo
    [J]. JOURNAL OF HYPERTENSION, 2020, 38 (06) : 1190 - 1191
  • [10] Angioedema Related to Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
    Nguyen, Timothy
    [J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2018, 14 (09): : 690 - 691
12345